Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the 2021 Synthetic Biology: Engineering, Evolution &
Yield10 Bioscience (NASDAQ:YTEN) reported Q1 sales of $196.00 thousand. Earnings fell to a loss of $2.55 million, resulting in a 2.22% decrease from last quarter. Yield10 Bioscience collected $195.00 thousand in revenue during Q4, but reported earnings showed a $2.61 million loss.
Check out the full agenda via Benzinga's Events page: https://www.benzinga.com/events/small-cap/global/#agenda
* the list below is limited to some of the publicly-traded companies that will be presenting